Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

Key Findings

• ●VEGF levels decreased after bevacizumab in all patients
• ●4 of 6 patients had no clinical response, 2 died
• ●Inhibiting VEGF alone may be insufficient — multiple cytokines upregulated

Referenced in (1 disease)